Glycobiology Industry Overview:

The global glycomics market is projected to reach USD 2.0 billion by 2025 from USD 1.0 billion in 2020, at a CAGR of 13.8% from 2020 to 2025. The growth of this market is mainly driven by the key factors driving the growth of the glycomics market: increasing R&D spending and funding for proteomics and glycomics research, growth of the proteomics market and technological advancements in glycomics devices.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132685525

Glycobiology Market - Breakdown of Primary Participants

Increased government and organizational investment has enabled academic researchers to develop new glycomics and glycobiology tools. This factor is expected to drive the sugar science segment, driving the overall market. Glycoproteomics require advanced analytical methods to study pathogens and human glycobiology in disease and health.

The enzymes segment accounted for the largest share of the glycomics market, by product

The glycomics market, by enzymes, has been categorized into five product segments, namely, enzymes, instruments, kits, carbohydrates, and reagents & chemicals. The enzymes segment is expected to dominate the market.

Glycomics market for drug discovery & development application is expected to grow at a high rate

By application, the glycomics market is segmented into drug discovery & development, disease diagnostics, and other applications. Drug discovery & development is the largest and the fastest-growing application segment in the glycomics market.

North America is the largest regional market for glycomics products

North America is expected to dominate the global glycomics market, followed by Europe. The largest share of North America is mainly attributed to increasing funding on glycomics research, rising R&D expenditure for drug discovery & development, and the presence of all key players.

Some prominent players in the global western blotting market Include:

The prominent players operating in the glycomics market include Merck KGaA (Germany), Agilent Technologies (US), Thermo Fisher Scientific (US), New England Biolabs (US), Shimadzu Corporation (Japan), Takara Bio (Japan), S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan), Waters Corporation (US), Asparia Glycomics S.L. (Spain), Bio-Techne (US), Bruker Corporation (US), Danaher Corporation (US), RayBiotech (US), Z Biotech (US), Chemily Glycoscience (US), Dextra Laboratories (UK), Lectenz Bio (US), and Ludger Ltd. (UK).

Request for sample pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=132685525

Glycomics Market Segmentation

MarketsandMarkets has segmented the Glycomics Market based on Product Type, application, and region:

Product

Enzymes
Glycosidases & Neuramidases
Glycosyltransferases & Sialytransferases
Other Enzymes (Carbohydrate kinases, carbohydrate sulfotransferases, protein sulfotransferases, and sulfatases)
Instruments
Mass Spectrometry Instruments
Chromatography Instruments
Arrays
Other Instruments (electrophoresis instruments, NMR instruments, and HPLC columns)
Kits
Glycan Releasing Kits
Glycan Labeling Kits
Glycan Purification Kits
Other Kits (glycan detection kits, glycan enrichment kits, and glycan sample preparation kits)
Carbohydrates
Oligosaccharides
Monosaccharides
Other Carbohydrates (rare sugars, glycoproteins, glycolipids, and glycol peptides)
Reagents & Chemicals
Application

Drug Discovery & Development
Disease Diagnostics
Other Applications (virology, cell biology, and microbiology)
End-user

Academic Research Institutes
Pharmaceutical and Biotechnology Companies
Clinical Laboratories
Region

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
Rest of Asia Pacific
Rest of the World
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa